journal article·2020-03

Investigation of natural minerals for ulcerative colitis therapy

Zhiya Sun, Mei Long, Xinxuan Liu, Yi Zhang, Shunxiang Li, Limei Bai, Huaming Yang

Publisher page

Abstract

Abstract Ulcerative colitis (UC) affects millions of people worldwide and is currently incurable. As such, there is an urgent need for effective drugs that will promote UC remission. This study investigated the therapeutic effects of five typical natural minerals on UC induced by dextran sulfate sodium (DSS): kaolinite (Kaol), halloysite (Hal), diatomite (Dia), montmorillonite (Mt), and palygorskite (Pal). These minerals were characterized by lamellar, tubular, columnar porous, and fibrous morphologies, as well as centered size distribution and negative charge. In vivo experiments indicated that natural minerals had a remission effect on UC and altered gut flora, especially Kaol. These results suggest that natural minerals can serve as drugs, or drug carriers, to attain synergistic effects with other drugs for UC therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Therapeutic Uses of Natural Elements · Clay minerals and soil interactions · Microscopic Colitis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (77)

Show source-provided references
1. Enteral nutrition support to treat malnutrition in inflammatory bowel disease10.3390/nu7042125 ↗
2. Kaolinite in pharmaceutics and biomedicine10.1016/j.ijpharm.2017.09.056 ↗
3. High dietary intake of specific fatty acids increases risk of flares in patients with ulcerative colitis in remission during treatment with aminosalicylates10.1016/j.cgh.2016.12.036 ↗
4. Biopharmaceutical improvement of praziquantel by interaction with montmorillonite and sepiolite10.1016/j.clay.2017.12.024 ↗
5. Assembling kaolinite nanotube at water/oil interface for enhancing Pickering emulsion stability10.1016/j.clay.2019.02.021 ↗
6. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients10.1016/j.clay.2009.10.016 ↗
7. Chassaing · 2014
8. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue10.1016/j.colsurfb.2018.05.012 ↗
9. Modulation of intestine development by fecal microbiota transplantation in suckling pigs10.1039/C7RA11234C ↗
10. Synthesis and characterization of nesquehonite (MgCO3·3H2O) powders from natural talc10.1016/j.powtec.2016.01.037 ↗
11. Behavior of talc and mica in copper ore flotation10.1016/j.clay.2018.02.011 ↗
12. Biomedical applications of cationic clay minerals10.1039/C4RA16945J ↗
13. Current understanding of the human microbiome10.1038/nm.4517 ↗
14. Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: clinical practice guidelines of the Italian Group for the study of inflammatory bowel disease10.1016/j.dld.2017.01.161 ↗
15. Green fabrication of ovalbumin nanoparticles as natural polyphenol carriers for ulcerative colitis therapy10.1021/acssuschemeng.8b01613 ↗
16. Positioning therapy for ulcerative colitis10.1007/s11894-015-0454-0 ↗
17. Polymeric nanocomposite: development, characterization, ex vivo and in vivo evaluation for ulcerative colitis10.1080/00914037.2015.1119690 ↗
18. Vasoactive intestinal peptide nanomedicine for the management of inflammatory bowel disease10.1021/acs.molpharmaceut.7b00452 ↗
19. Time-efficient preparation and mechanism of methoxy-grafted kaolinite via acid treatment and heating10.1016/j.clay.2019.04.001 ↗
20. Interaction of biological molecules with clay minerals: a combined spectroscopic and sorption study of lysozyme on saponite10.1021/la203161n ↗
21. Highly-effective phosphate removal from aqueous solutions by calcined nano-porous palygorskite matrix with embedded lanthanum hydroxide10.1016/j.clay.2018.07.005 ↗
22. Regulation of clay particles charge for design of protective electrokinetic barriers10.1016/j.jhazmat.2018.06.023 ↗
23. Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon10.1016/j.biomaterials.2010.09.062 ↗
24. Influence of environmental factors in the development of inflammatory bowel diseases10.4292/wjgpt.v7.i1.112 ↗
25. Chitosan modified halloysite nanotubes as emerging porous microspheres for drug carrier10.1016/j.clay.2016.03.035 ↗
26. ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling
27. Methoxy-grafted kaolinite preparation by intercalation of methanol: mechanism of its structural variability10.1016/j.clay.2016.12.031 ↗
28. Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity10.1016/j.psychres.2017.08.052 ↗
29. In vitro hemocompatibility and cytotoxicity evaluation of halloysite nanotubes for biomedical application10.1155/2015/685323 ↗
30. Tea polysaccharides inhibit colitis-associated colorectal cancer via interleukin-6/STAT3 pathway10.1021/acs.jafc.8b00710 ↗
31. Fe2O3 nanoparticles anchored on 2D kaolinite with enhanced antibacterial activity10.1039/C7CC02905E ↗
32. Emerging nanoclay composite for effective hemostasis10.1002/adfm.201704452 ↗
33. Characterization of kaolinite-cetyltrimethylammonium chloride intercalation complex synthesized through eco-friend kaolinite-urea pre-intercalation complex10.1016/j.colsurfa.2016.08.035 ↗
34. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics10.1021/pr100574p ↗
35. Clay nanoparticles for regenerative medicine and biomaterial design: a review of clay bioactivity10.1016/j.biomaterials.2017.12.024 ↗
36. Amine-impregnated mesoporous silica nanotube as an emerging nanocomposite for CO2 capture10.1021/acsami.6b05044 ↗
37. Engineered nanomaterials for infection control and healing acute and chronic wounds10.1021/acsami.6b00291 ↗
38. Emerging parallel dual 2D composites: natural clay mineral hybridizing MoS2 and interfacial structure10.1002/adfm.201504942 ↗
39. Inorganic hemostats: the state-of-the-art and recent advances10.1016/j.msec.2015.09.008 ↗
40. Highly effective adsorption of crystal violet dye from contaminated water using graphene oxide intercalated montmorillonite nanocomposite10.1016/j.clay.2018.09.012 ↗
41. DNA facilitates the sorption of polycyclic aromatic hydrocarbons on montmorillonites10.1021/acs.est.7b05174 ↗
42. Defensins and inflammation: the role of defensins in inflammatory bowel disease10.1111/j.1440-1746.2008.05772.x ↗
43. Gastrointestinal and liver adverse effects of drugs used for treating IBD10.1016/j.bpg.2009.10.011 ↗
44. Rouquerol · 1999
45. Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties10.1016/j.carbpol.2013.10.029 ↗
46. Halloysite and chitosan oligosaccharide nanocomposite for wound healing10.1016/j.actbio.2017.05.032 ↗
47. Obtaining the palygorskite:chitosan composite for modified release of 5-aminosalicylic acid10.1016/j.msec.2016.12.068 ↗
48. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease10.1002/ibd.20101 ↗
49. Effects of copper-exchanged montmorillonite, as alternative to antibiotic, on diarrhea, intestinal permeability and proinflammatory cytokine of weanling pigs10.1016/j.clay.2013.01.016 ↗
50. Clay minerals mediate folding and regioselective interactions of RNA: a large-scale atomistic simulation study10.1021/ja104106y ↗
51. Methoxy-modified kaolinite as a novel carrier for high-capacity loading and controlled-release of the herbicide amitrole
52. Selective loading of 5-fluorouracil in the interlayer space of methoxy-modified kaolinite for controlled release10.1016/j.clay.2017.04.008 ↗
53. Effects of zinc-bearing clinoptilolite on growth performance, cecal microflora and intestinal mucosal function of broiler chickens10.1016/j.anifeedsci.2013.12.014 ↗
54. Cytocompatibility and uptake of polycations-modified halloysite clay nanotubes10.1016/j.clay.2018.12.016 ↗
55. The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease10.1177/2050640617708953 ↗
56. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures10.1007/s00330-011-2117-3 ↗
57. Montmorillonite dispersed single wall carbon nanotubes (SWCNTs)/TiO2 heterojunction composite for enhanced dynamic photocatalytic H2 production under visible light10.1016/j.clay.2019.03.029 ↗
58. Clay minerals in skin drug delivery10.1007/s42860-018-0003-7 ↗
59. Rational design of polyphenol-poloxamer nanovesicles for targeting inflammatory bowel disease therapy10.1021/acs.chemmater.8b01173 ↗
60. In situ synthesis of diatomite–carbon nanotube composite adsorbent and its adsorption characteristics for phenolic compounds10.1021/acs.jced.8b00874 ↗
61. Folate-conjugated halloysite nanotubes, an efficient drug carrier, deliver doxorubicin for targeted therapy of breast cancer10.1021/acsanm.7b00087 ↗
62. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis10.1016/j.jconrel.2018.08.021 ↗
63. Removal of fluoride by nature diatomite from high-fluorine water: An appropriate pretreatment for nanofiltration process10.1016/j.desal.2015.04.033 ↗
64. Electrospun microfiber membranes embedded with drug-loaded clay nanotubes for sustained antimicrobial protection10.1021/nn506255e ↗
65. In situ loading of highly-dispersed CuO nanoparticles on hydroxyl group-rich SiO2-AlOOH composite nanosheets for CO catalytic oxidation10.1016/j.cej.2017.02.043 ↗
66. Amino-functionalized hierarchical porous SiO2-AlOOH composite nanosheets with enhanced adsorption performance10.1016/j.jhazmat.2017.11.058 ↗
67. Green assembly of stable and uniform silver nanoparticles on 2D silica nanosheets for catalytic reduction of 4-nitrophenol10.1016/j.apcatb.2017.12.040 ↗
68. From natural attapulgite to mesoporous materials: Methodology, characterization and structural evolution10.1021/jp911516b ↗
69. DNA materials: Bridging nanotechnology and biotechnology10.1021/ar5001082 ↗
70. Adsorption of proteins and nucleic acids on clay minerals and their interactions: a review10.1016/j.clay.2013.06.003 ↗
71. Cathelicidin-BF, a novel antimicrobial peptide from bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis10.1021/acs.molpharmaceut.5b00069 ↗
72. An emerging dual collaborative strategy for high-performance tumor therapy with mesoporous silica nanotubes loaded with Mn3O410.1039/C6TB01788F ↗
73. Applications and interfaces of halloysite nanocomposites10.1016/j.clay.2015.06.034 ↗
74. Intercalated 2D nanoclay for emerging drug delivery in cancer therapy10.1007/s12274-017-1466-x ↗
75. Chemically modified kaolinite nanolayers for the removal of organic pollutants10.1016/j.clay.2018.03.009 ↗
76. Nanoclay-modulated oxygen vacancies of metal oxide10.1038/s42004-019-0112-9 ↗
77. Mitigation of colitis with NovaSil clay therapy10.1007/s10620-014-3360-7 ↗